Psilocybin, the psychedelic substance in “magic” mushrooms, is generating lots of interest as a potential treatment for a host of mental ills, but new research warns there is little data on how it might interact with more traditional psychiatric medications. “There’s a major incongruence between the public enthusiasm and exuberance with psychedelic substances for mental…  read on >  read on >

Something as simple as aspirin may help lower the risk of death in hospital patients who are fighting a tough case of COVID-19, a new study found. George Washington University researchers analyzed data on more than 112,000 patients hospitalized with moderate COVID-19 at 64 health systems in the United States from Jan. 1, 2020, through…  read on >  read on >

Nearly 60 million Americans live in “dental deserts,” while many more can’t afford basic dental care even if it is available. Enter dental therapists. New research suggests these newly minted health care professionals could help more people get the oral health care they need in low-income areas. They are fast becoming members of a typical…  read on >  read on >

(HealthDay News) — The new Omicron subvariant, BA.2, is spreading across the United States and will soon take over as the major COVID variant, White House chief medical adviser Dr. Anthony Fauci said Tuesday. “Ultimately it will be the predominant variant in this country,” Fauci told HealthDay. “It’s occupying about 85% of the variants in…  read on >  read on >

Millions of people taking statin drugs to lower their cholesterol may get an unanticipated benefit: They may be less likely to develop movement and balance problems like those seen in Parkinson’s disease, a new study suggests. The study looked at the relationship between statin use and parkinsonism. People with parkinsonism have some of the symptoms…  read on >  read on >